Woodline Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.8M | Sell |
91,664
-61,496
| -40% | -$27.4M | 0.22% | 133 |
|
|
2025
Q1 | $74.3M | Buy |
153,160
+3,742
| +3% | +$1.81M | 0.48% | 32 |
|
|
2024
Q4 | $60.2M | Buy |
149,418
+16,653
| +13% | +$6.71M | 0.41% | 57 |
|
|
2024
Q3 | $61.7M | Buy |
+132,765
| New | +$61.7M | 0.52% | 43 |
|
|
2024
Q1 | – | Sell |
-2,742
| Closed | -$1.12M | – | 640 |
|
|
2023
Q4 | $1.12M | Buy |
+2,742
| New | +$1.12M | 0.01% | 398 |
|
|
2022
Q2 | – | Sell |
-74,671
| Closed | -$19.5M | – | 896 |
|
|
2022
Q1 | $19.5M | Sell |
74,671
-29,109
| -28% | -$7.6M | 0.32% | 95 |
|
|
2021
Q4 | $22.8M | Buy |
103,780
+23,293
| +29% | +$5.12M | 0.33% | 74 |
|
|
2021
Q3 | $14.6M | Sell |
80,487
-83,577
| -51% | -$15.2M | 0.24% | 116 |
|
|
2021
Q2 | $33.1M | Sell |
164,064
-50,012
| -23% | -$10.1M | 0.62% | 41 |
|
|
2021
Q1 | $46M | Buy |
+214,076
| New | +$46M | 1.02% | 19 |
|